Primary breast cancer
The purpose of this study was to identify genes that marks and mediates breast cancer metastasis to the lungs.
--
A cohort of 82 breast cancer patients treated at the Memorial Sloan-Kettering Cancer Center, New York was used in a univariate Cox proportional hazards model to relate the expression level of each lung metastasis signature gene with clinical outcome.
--
--
For the primary breast tumour data, tissues from primary breast cancers were obtained from therapeutic procedures performed as part of routine clinical management. Samples were snap-frozen in liquid nitrogen and stored at ?80 °C. Each sample was examined histologically in cryostat sections stained with hematoxylin and eosin. Regions were dissected manually from the frozen block to provide a consistent tumour cell content of greater than 70% in tissues used for analysis.
Minn, Andy J., Gaorav P. Gupta, Peter M. Siegel, Paula D. Bos, Weiping Shu, Dilip D. Giri, Agnes Viale, Adam B. Olshen, William L. Gerald, and Joan Massagué. “Genes That Mediate Breast Cancer Metastasis to Lung.” Nature 436, no. 7050 (July 28, 2005): 518–24. doi:10.1038/nature03799.
Sample ID | series | IMS | IBS | IDS | ICR |
---|---|---|---|---|---|
GSM50034 | NA | Her2 | IBD | WID | ICR3 |
GSM50035 | NA | Basal | IBE | WID | ICR2 |
GSM50036 | NA | LumA | IBD | FID | ICR3 |
GSM50037 | NA | LumB | IBE | PID | ICR1 |
GSM50038 | NA | LumB | IBD | WID | ICR2 |
All fields are editable except the "Sample ID" column. To edit a cell, click within the cell. To edit a "date" cell, click on the calendar icon. To cancel an edit, press the ESC key.
Sample ID | Series | IMS | IBS | IDS | ICR | Array Sample ID | Sample Title | DMFS 10Y EVENT | DMFS 10Y TIME | Disease Free Survival Event | Distant Met Free Survival Event | Distant Met Free Survival | Age At Initial Pathologic Diagnosis | Lymph Node Status | ER Status | PR Status | Histology Differentiation Grade | Tumor Size Cm | Pathology T Stage | Bone Metastasis Event | Disease Free Survival Years | Lung Metastasis Event | Lymph Node Examined Count | RFS 5Y EVENT | Bone Metastasis Free Survival Years | HER2 IHC | Lung Metastasis Free Survival Years | Number Of Lymph Nodes Positive | Van T Veer Signature |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSM50034 | NA |
Her2 |
IBD |
WID |
ICR3 |
400003089 |
B110-T |
DistantMetastasisFree |
7.25 |
DiseaseFree |
NA |
NA |
61 |
NA |
ER- |
PR- |
NA |
2.2 |
T2 |
BoneMetastasisFree |
7.25 |
LungMetastasisFree |
11 |
0 |
7.25 |
3+ |
7.25 |
2 |
Good Prognosis |
GSM50035 | NA |
Basal |
IBE |
WID |
ICR2 |
400003090 |
B114-T |
DistantMetastasis |
1.84 |
Recurred/Progressed |
NA |
NA |
61 |
NA |
ER- |
PR- |
NA |
3.8 |
T2 |
BoneMetastasisFree |
1.84 |
LungMetastasis |
19 |
1 |
1.84 |
N |
1.84 |
3 |
Bad Prognosis |
GSM50036 | NA |
LumA |
IBD |
FID |
ICR3 |
400003091 |
B52-T |
DistantMetastasisFree |
9.15 |
DiseaseFree |
NA |
NA |
40 |
NA |
ER+ |
PR+ |
NA |
3 |
T2 |
BoneMetastasisFree |
9.15 |
LungMetastasisFree |
19 |
0 |
9.15 |
N |
9.15 |
0 |
Bad Prognosis |
GSM50037 | NA |
LumB |
IBE |
PID |
ICR1 |
400003092 |
B54-T |
DistantMetastasisFree |
6.86 |
DiseaseFree |
NA |
NA |
40 |
NA |
ER+ |
PR+ |
NA |
2.8 |
T2 |
BoneMetastasisFree |
6.86 |
LungMetastasisFree |
26 |
0 |
6.86 |
NA |
6.86 |
0 |
Good Prognosis |
GSM50038 | NA |
LumB |
IBD |
WID |
ICR2 |
400003093 |
B55-T |
DistantMetastasisFree |
6.47 |
DiseaseFree |
NA |
NA |
75 |
NA |
ER+ |
PR- |
NA |
2.2 |
T2 |
BoneMetastasisFree |
6.47 |
LungMetastasisFree |
15 |
0 |
6.47 |
1+ |
6.47 |
0 |
Good Prognosis |
GSM50039 | NA |
LumB |
IBE |
FID |
ICR4 |
400003094 |
B56-T |
DistantMetastasisFree |
7.08 |
DiseaseFree |
NA |
NA |
55 |
NA |
ER+ |
PR+ |
NA |
2.1 |
T2 |
BoneMetastasisFree |
7.08 |
LungMetastasisFree |
19 |
0 |
7.08 |
N |
7.08 |
0 |
Good Prognosis |
GSM50040 | NA |
Basal |
IBE |
WID |
ICR2 |
400003095 |
B57-T |
DistantMetastasisFree |
7.57 |
DiseaseFree |
NA |
NA |
57 |
NA |
ER- |
PR- |
NA |
2.8 |
T2 |
BoneMetastasisFree |
7.57 |
LungMetastasisFree |
19 |
0 |
7.57 |
N |
7.57 |
0 |
Bad Prognosis |
GSM50041 | NA |
NA |
NA |
NA |
NA |
400003096 |
B59-T |
NA |
NA |
NA |
NA |
NA |
73 |
NA |
ER- |
NA |
NA |
3.5 |
T2 |
NA |
NA |
NA |
9 |
NA |
NA |
NA |
NA |
0 |
NA |
GSM50042 | NA |
Basal |
IBE |
PID |
ICR3 |
400003097 |
B61-T |
DistantMetastasisFree |
4.41 |
DiseaseFree |
NA |
NA |
73 |
NA |
ER- |
PR- |
NA |
3.5 |
T2 |
BoneMetastasisFree |
4.41 |
LungMetastasisFree |
35 |
NA |
4.41 |
N |
4.41 |
0 |
Bad Prognosis |
GSM50043 | NA |
LumB |
IBE |
PID |
ICR1 |
400003098 |
B62-T |
DistantMetastasisFree |
5.23 |
DiseaseFree |
NA |
NA |
63 |
NA |
ER+ |
PR- |
NA |
5 |
T2 |
BoneMetastasisFree |
5.23 |
LungMetastasisFree |
15 |
0 |
5.23 |
1+ |
5.23 |
0 |
Good Prognosis |
GSM50044 | NA |
LumB |
IBD |
PID |
ICR1 |
400003099 |
B63-T |
DistantMetastasisFree |
5.62 |
DiseaseFree |
NA |
NA |
64 |
NA |
ER+ |
PR- |
NA |
3.2 |
T2 |
BoneMetastasisFree |
5.62 |
LungMetastasisFree |
27 |
0 |
5.62 |
N |
5.62 |
0 |
Good Prognosis |
GSM50045 | NA |
ClaudinLow |
IBD |
PID |
ICR1 |
400003100 |
B66-T |
DistantMetastasisFree |
10 |
DiseaseFree |
NA |
NA |
58 |
NA |
ER- |
PR- |
NA |
2.8 |
T2 |
BoneMetastasisFree |
10.75 |
LungMetastasisFree |
31 |
0 |
10.75 |
NA |
10.75 |
0 |
Bad Prognosis |
GSM50046 | NA |
Basal |
IBE |
FID |
ICR4 |
400003101 |
B67-T |
DistantMetastasisFree |
8.04 |
DiseaseFree |
NA |
NA |
32 |
NA |
ER- |
PR- |
NA |
1.8 |
T1c |
BoneMetastasisFree |
8.04 |
LungMetastasisFree |
18 |
0 |
8.04 |
N |
8.04 |
0 |
Bad Prognosis |
GSM50047 | NA |
LumA |
IBD |
WID |
ICR2 |
400003102 |
B68-T |
DistantMetastasisFree |
5.41 |
DiseaseFree |
NA |
NA |
86 |
NA |
ER+ |
PR+ |
NA |
3.2 |
T2 |
BoneMetastasisFree |
5.41 |
LungMetastasisFree |
18 |
0 |
5.41 |
N |
5.41 |
0 |
Bad Prognosis |
GSM50048 | NA |
Basal |
IBE |
PID |
ICR1 |
400003103 |
B69-T |
DistantMetastasisFree |
6.07 |
DiseaseFree |
NA |
NA |
49 |
NA |
ER- |
PR- |
NA |
1.5 |
T1c |
BoneMetastasisFree |
6.07 |
LungMetastasisFree |
6 |
0 |
6.07 |
N |
6.07 |
0 |
Bad Prognosis |
GSM50049 | NA |
LumA |
IBD |
PID |
ICR1 |
400003104 |
B71-T |
DistantMetastasisFree |
5.5 |
DiseaseFree |
NA |
NA |
46 |
NA |
ER+ |
PR+ |
NA |
2.1 |
T2 |
BoneMetastasisFree |
5.5 |
LungMetastasisFree |
18 |
0 |
5.5 |
N |
5.5 |
0 |
Good Prognosis |
GSM50050 | NA |
NA |
NA |
NA |
NA |
400003105 |
B72-T |
NA |
NA |
NA |
NA |
NA |
63 |
NA |
ER- |
PR- |
NA |
1.1 |
T1c |
NA |
NA |
NA |
18 |
NA |
NA |
NA |
NA |
0 |
NA |
GSM50051 | NA |
LumA |
IBD |
WID |
ICR2 |
400003106 |
B74-T |
DistantMetastasisFree |
3.77 |
DiseaseFree |
NA |
NA |
49 |
NA |
ER+ |
PR+ |
NA |
6 |
T3/T4 |
BoneMetastasisFree |
3.77 |
LungMetastasisFree |
21 |
NA |
3.77 |
N |
3.77 |
0 |
Good Prognosis |
GSM50052 | NA |
Basal |
IBE |
WID |
ICR3 |
400003107 |
B75-T |
DistantMetastasisFree |
4.56 |
DiseaseFree |
NA |
NA |
47 |
NA |
ER- |
PR- |
NA |
5 |
T2 |
BoneMetastasisFree |
4.56 |
LungMetastasisFree |
8 |
NA |
4.56 |
0-1 |
4.56 |
0 |
Bad Prognosis |
GSM50053 | NA |
LumA |
IBD |
WID |
ICR2 |
400003108 |
B76-T |
DistantMetastasisFree |
3.97 |
DiseaseFree |
NA |
NA |
82 |
NA |
ER+ |
PR+ |
NA |
2 |
T1c |
BoneMetastasisFree |
3.97 |
LungMetastasisFree |
3 |
NA |
3.97 |
N |
3.97 |
0 |
Bad Prognosis |
GSM50054 | NA |
ClaudinLow |
IBD |
WID |
ICR3 |
400003109 |
B77-T |
DistantMetastasisFree |
4.05 |
DiseaseFree |
NA |
NA |
73 |
NA |
ER- |
PR- |
NA |
3 |
T2 |
BoneMetastasisFree |
4.05 |
LungMetastasisFree |
16 |
NA |
4.05 |
0-1 |
4.05 |
0 |
Bad Prognosis |
GSM50055 | NA |
NA |
NA |
NA |
NA |
400003110 |
B53-T |
NA |
NA |
NA |
NA |
NA |
33 |
NA |
ER- |
PR- |
NA |
3.5 |
T2 |
NA |
NA |
NA |
15 |
NA |
NA |
0-1 |
NA |
0 |
NA |
GSM50056 | NA |
NA |
NA |
NA |
NA |
400003111 |
B58-T |
NA |
NA |
NA |
NA |
NA |
70 |
NA |
ER+ |
PR- |
NA |
5 |
T2 |
NA |
NA |
NA |
26 |
NA |
NA |
NA |
NA |
0 |
NA |
GSM50057 | NA |
NA |
NA |
NA |
NA |
400003112 |
B60-T |
NA |
NA |
NA |
NA |
NA |
46 |
NA |
ER- |
PR- |
NA |
4 |
T2 |
NA |
NA |
NA |
39 |
NA |
NA |
3+ |
NA |
0 |
NA |
GSM50058 | NA |
NA |
NA |
NA |
NA |
400003113 |
B70-T |
NA |
NA |
NA |
NA |
NA |
51 |
NA |
ER- |
PR- |
NA |
4 |
T2 |
NA |
NA |
NA |
16 |
NA |
NA |
2+ |
NA |
0 |
NA |
GSM50059 | NA |
LumB |
IBD |
PID |
ICR3 |
400003114 |
B42-T |
DistantMetastasisFree |
7.63 |
DiseaseFree |
NA |
NA |
73 |
NA |
ER+ |
PR+ |
NA |
2.9 |
T2 |
BoneMetastasisFree |
7.63 |
LungMetastasisFree |
16 |
0 |
7.63 |
N |
7.63 |
0 |
Good Prognosis |
GSM50060 | NA |
Her2 |
IBE |
PID |
ICR1 |
400003115 |
B43-T |
DistantMetastasis |
3.47 |
Recurred/Progressed |
NA |
NA |
52 |
NA |
ER- |
PR- |
NA |
4.5 |
T2 |
BoneMetastasisFree |
3.47 |
LungMetastasis |
26 |
1 |
4.62 |
1+ |
3.47 |
0 |
Bad Prognosis |
GSM50061 | NA |
ClaudinLow |
IBD |
WID |
ICR3 |
400003116 |
B44-T |
DistantMetastasis |
3.96 |
Recurred/Progressed |
NA |
NA |
61 |
NA |
ER- |
PR- |
NA |
6 |
T3/T4 |
BoneMetastasis |
3.96 |
LungMetastasis |
26 |
1 |
3.96 |
N |
3.96 |
0 |
Good Prognosis |
GSM50062 | NA |
LumB |
IBE |
PID |
ICR1 |
400003117 |
B45-T |
DistantMetastasis |
3.07 |
Recurred/Progressed |
NA |
NA |
68 |
NA |
ER+ |
PR+ |
NA |
3.5 |
T2 |
BoneMetastasisFree |
3.07 |
LungMetastasisFree |
23 |
1 |
6.17 |
N |
6.17 |
0 |
Good Prognosis |
GSM50063 | NA |
ClaudinLow |
IBD |
PID |
ICR1 |
400003118 |
B46-T |
DistantMetastasis |
3.11 |
Recurred/Progressed |
NA |
NA |
49 |
NA |
ER- |
PR- |
NA |
3.2 |
T2 |
BoneMetastasisFree |
3.11 |
LungMetastasis |
36 |
1 |
5.71 |
N |
3.11 |
0 |
Bad Prognosis |
GSM50064 | NA |
Normal |
IBE |
NA |
ICR3 |
400003119 |
B47-T |
DistantMetastasis |
0.94 |
Recurred/Progressed |
NA |
NA |
70 |
NA |
ER- |
PR- |
NA |
6.5 |
T3/T4 |
BoneMetastasis |
0.94 |
LungMetastasis |
14 |
1 |
0.94 |
N |
1.34 |
0 |
Bad Prognosis |
GSM50065 | NA |
Her2 |
IBD |
WID |
ICR3 |
400003120 |
B48-T |
DistantMetastasisFree |
5.81 |
DiseaseFree |
NA |
NA |
54 |
NA |
ER+ |
PR- |
NA |
3 |
T2 |
BoneMetastasisFree |
5.81 |
LungMetastasisFree |
11 |
0 |
5.81 |
3+ |
5.81 |
0 |
Bad Prognosis |
GSM50066 | NA |
ClaudinLow |
IBD |
WID |
ICR3 |
400003121 |
B49-T |
DistantMetastasis |
1.24 |
Recurred/Progressed |
NA |
NA |
80 |
NA |
ER- |
PR- |
NA |
2 |
T1c |
BoneMetastasis |
1.24 |
LungMetastasis |
4 |
1 |
1.24 |
N |
1.24 |
0 |
Bad Prognosis |
GSM50067 | NA |
Basal |
IBE |
PID |
ICR2 |
400003122 |
B50-T |
DistantMetastasis |
0.77 |
Recurred/Progressed |
NA |
NA |
78 |
NA |
ER- |
PR- |
NA |
3 |
T2 |
BoneMetastasisFree |
0.77 |
LungMetastasis |
2 |
1 |
0.95 |
N |
0.77 |
0 |
Bad Prognosis |
GSM50068 | NA |
LumA |
IBD |
WID |
ICR2 |
400003123 |
B51-T |
DistantMetastasis |
3.48 |
Recurred/Progressed |
NA |
NA |
57 |
NA |
ER+ |
PR- |
NA |
1.7 |
T1c |
BoneMetastasisFree |
3.48 |
LungMetastasis |
17 |
1 |
6.01 |
N |
3.48 |
0 |
Bad Prognosis |
GSM50069 | NA |
Basal |
IBD |
PID |
ICR2 |
400003124 |
B73-T |
DistantMetastasis |
3.83 |
Recurred/Progressed |
NA |
NA |
73 |
NA |
ER- |
PR- |
NA |
3.2 |
T2 |
BoneMetastasisFree |
3.83 |
LungMetastasis |
17 |
1 |
4.01 |
N |
3.83 |
0 |
Bad Prognosis |
GSM50070 | NA |
Her2 |
IBD |
FID |
ICR4 |
400003125 |
B98-T |
DistantMetastasis |
3.36 |
Recurred/Progressed |
NA |
NA |
58 |
NA |
ER- |
PR- |
NA |
2 |
T1c |
BoneMetastasis |
3.36 |
LungMetastasisFree |
16 |
1 |
3.36 |
N |
6.96 |
3 |
Bad Prognosis |
GSM50071 | NA |
Her2 |
IBD |
FID |
ICR3 |
400003126 |
B100-T |
DistantMetastasisFree |
5.82 |
DiseaseFree |
NA |
NA |
78 |
NA |
ER- |
PR- |
NA |
2.5 |
T2 |
BoneMetastasisFree |
5.82 |
LungMetastasisFree |
14 |
0 |
5.82 |
N |
5.82 |
2 |
Bad Prognosis |
GSM50072 | NA |
Basal |
IBE |
FID |
ICR4 |
400003127 |
B101-T |
DistantMetastasisFree |
10 |
DiseaseFree |
NA |
NA |
47 |
NA |
ER- |
PR- |
NA |
3.5 |
T2 |
BoneMetastasisFree |
10.74 |
LungMetastasisFree |
26 |
0 |
10.74 |
3+ |
10.74 |
2 |
Bad Prognosis |
GSM50073 | NA |
Basal |
IBE |
FID |
ICR4 |
400003128 |
B102-T |
DistantMetastasisFree |
7.25 |
DiseaseFree |
NA |
NA |
50 |
NA |
ER- |
PR- |
NA |
4 |
T2 |
BoneMetastasisFree |
7.25 |
LungMetastasisFree |
29 |
0 |
7.25 |
N |
7.25 |
2 |
Bad Prognosis |
GSM50074 | NA |
LumA |
IBD |
WID |
ICR1 |
400003129 |
B104-T |
DistantMetastasisFree |
7.32 |
DiseaseFree |
NA |
NA |
49 |
NA |
ER+ |
PR- |
NA |
2.95 |
T2 |
BoneMetastasisFree |
7.32 |
LungMetastasisFree |
19 |
0 |
7.32 |
N |
7.32 |
3 |
Good Prognosis |
GSM50075 | NA |
ClaudinLow |
IBD |
WID |
ICR2 |
400003130 |
B105-T |
DistantMetastasisFree |
7.32 |
DiseaseFree |
NA |
NA |
49 |
NA |
ER+ |
PR+ |
NA |
2.95 |
T2 |
BoneMetastasisFree |
7.32 |
LungMetastasisFree |
19 |
0 |
7.32 |
N |
7.32 |
3 |
Bad Prognosis |
GSM50076 | NA |
NA |
NA |
NA |
NA |
400003131 |
B106-T |
NA |
NA |
NA |
NA |
NA |
57 |
NA |
ER+ |
PR+ |
NA |
2.1 |
T2 |
NA |
NA |
NA |
16 |
NA |
NA |
N |
NA |
2 |
NA |
GSM50077 | NA |
NA |
NA |
NA |
NA |
400003132 |
B107-T |
NA |
NA |
NA |
NA |
NA |
57 |
NA |
ER+ |
PR+ |
NA |
2.1 |
T2 |
NA |
NA |
NA |
16 |
NA |
NA |
N |
NA |
2 |
NA |
GSM50078 | NA |
Basal |
IBE |
PID |
ICR1 |
400003133 |
B112-T |
DistantMetastasisFree |
6.98 |
DiseaseFree |
NA |
NA |
41 |
NA |
ER- |
PR+ |
NA |
4 |
T2 |
BoneMetastasisFree |
6.98 |
LungMetastasisFree |
20 |
0 |
6.98 |
N |
6.98 |
1 |
Bad Prognosis |
GSM50079 | NA |
Basal |
IBE |
WID |
ICR3 |
400003134 |
B115-T |
DistantMetastasisFree |
6.52 |
DiseaseFree |
NA |
NA |
40 |
NA |
ER- |
PR- |
NA |
5 |
T2 |
BoneMetastasisFree |
6.52 |
LungMetastasisFree |
16 |
0 |
6.52 |
N |
6.52 |
3 |
Bad Prognosis |
GSM50080 | NA |
LumA |
IBD |
PID |
ICR1 |
400003135 |
B78-T |
DistantMetastasisFree |
7.25 |
DiseaseFree |
NA |
NA |
41 |
NA |
ER+ |
PR+ |
NA |
2 |
T1c |
BoneMetastasisFree |
7.25 |
LungMetastasisFree |
28 |
0 |
7.25 |
N |
7.25 |
2 |
Good Prognosis |
GSM50081 | NA |
LumA |
IBD |
PID |
ICR2 |
400003136 |
B79-T |
DistantMetastasisFree |
5.07 |
DiseaseFree |
NA |
NA |
81 |
NA |
ER+ |
PR+ |
NA |
2.4 |
T2 |
BoneMetastasisFree |
5.07 |
LungMetastasisFree |
12 |
0 |
5.07 |
NA |
5.07 |
1 |
Good Prognosis |
GSM50082 | NA |
Normal |
IBE |
NA |
ICR1 |
400003137 |
B80-T |
DistantMetastasisFree |
7.11 |
DiseaseFree |
NA |
NA |
49 |
NA |
ER+ |
PR+ |
NA |
2.2 |
T2 |
BoneMetastasisFree |
7.11 |
LungMetastasisFree |
37 |
0 |
7.11 |
2+ |
7.11 |
3 |
Good Prognosis |
GSM50083 | NA |
LumA |
IBD |
PID |
ICR2 |
400003138 |
B82-T |
DistantMetastasisFree |
7.28 |
DiseaseFree |
NA |
NA |
61 |
NA |
ER+ |
PR+ |
NA |
2.5 |
T2 |
BoneMetastasisFree |
7.28 |
LungMetastasisFree |
21 |
0 |
7.28 |
N |
7.28 |
1 |
Good Prognosis |
GSM50084 | NA |
Normal |
IBE |
NA |
ICR2 |
400003139 |
B83-T |
DistantMetastasisFree |
6.4 |
DiseaseFree |
NA |
NA |
39 |
NA |
ER+ |
PR+ |
NA |
4 |
T2 |
BoneMetastasisFree |
6.4 |
LungMetastasisFree |
23 |
0 |
6.4 |
1+ |
6.4 |
1 |
Good Prognosis |
GSM50085 | NA |
LumB |
IBE |
PID |
ICR2 |
400003140 |
B84-T |
DistantMetastasisFree |
6.5 |
DiseaseFree |
NA |
NA |
37 |
NA |
ER+ |
PR+ |
NA |
2.3 |
T2 |
BoneMetastasisFree |
6.5 |
LungMetastasisFree |
22 |
0 |
6.5 |
2+ |
6.5 |
3 |
Good Prognosis |
GSM50086 | NA |
Her2 |
IBE |
WID |
ICR4 |
400003141 |
B85-T |
DistantMetastasisFree |
8.31 |
DiseaseFree |
NA |
NA |
57 |
NA |
ER+ |
PR- |
NA |
4.3 |
T2 |
BoneMetastasisFree |
8.31 |
LungMetastasisFree |
18 |
0 |
8.31 |
N |
8.31 |
1 |
Good Prognosis |
GSM50087 | NA |
LumB |
IBD |
FID |
ICR3 |
400003142 |
B86-T |
DistantMetastasisFree |
8.31 |
DiseaseFree |
NA |
NA |
57 |
NA |
ER+ |
PR- |
NA |
4.3 |
T2 |
BoneMetastasisFree |
8.31 |
LungMetastasisFree |
18 |
0 |
8.31 |
N |
8.31 |
1 |
Good Prognosis |
GSM50088 | NA |
NA |
NA |
NA |
NA |
400003143 |
B87-T |
NA |
NA |
NA |
NA |
NA |
51 |
NA |
ER+ |
PR- |
NA |
2.5 |
T2 |
NA |
NA |
NA |
17 |
NA |
NA |
3+ |
NA |
1 |
NA |
GSM50089 | NA |
Normal |
IBE |
NA |
ICR2 |
400003144 |
B89-T |
DistantMetastasisFree |
8.74 |
DiseaseFree |
NA |
NA |
30 |
NA |
ER- |
PR- |
NA |
3 |
T2 |
BoneMetastasisFree |
8.74 |
LungMetastasisFree |
30 |
0 |
8.74 |
N |
8.74 |
3 |
Good Prognosis |
GSM50090 | NA |
LumA |
IBD |
PID |
ICR1 |
400003145 |
B90-T |
DistantMetastasisFree |
6.79 |
DiseaseFree |
NA |
NA |
34 |
NA |
ER+ |
PR+ |
NA |
4.3 |
T2 |
BoneMetastasisFree |
6.79 |
LungMetastasisFree |
21 |
0 |
6.79 |
NA |
6.79 |
1 |
Good Prognosis |
GSM50091 | NA |
LumB |
IBE |
WID |
ICR4 |
400003146 |
B91-T |
DistantMetastasisFree |
7.19 |
DiseaseFree |
NA |
NA |
84 |
NA |
ER+ |
PR- |
NA |
10 |
T3/T4 |
BoneMetastasisFree |
7.19 |
LungMetastasisFree |
11 |
0 |
7.19 |
N |
7.19 |
2 |
Good Prognosis |
GSM50092 | NA |
Her2 |
IBD |
WID |
ICR4 |
400003147 |
B93-T |
DistantMetastasisFree |
6.45 |
DiseaseFree |
NA |
NA |
50 |
NA |
ER- |
PR- |
NA |
2.3 |
T2 |
BoneMetastasisFree |
6.45 |
LungMetastasisFree |
29 |
0 |
6.45 |
N |
6.45 |
1 |
Bad Prognosis |
GSM50093 | NA |
Basal |
IBE |
FID |
ICR3 |
400003148 |
B97-T |
DistantMetastasisFree |
7.86 |
DiseaseFree |
NA |
NA |
64 |
NA |
ER- |
PR- |
NA |
2 |
T1c |
BoneMetastasisFree |
7.86 |
LungMetastasisFree |
20 |
0 |
7.86 |
N |
7.86 |
2 |
Bad Prognosis |
GSM50094 | NA |
Basal |
IBE |
PID |
ICR2 |
400003149 |
B103-T |
DistantMetastasis |
3.22 |
Recurred/Progressed |
NA |
NA |
57 |
NA |
ER- |
PR- |
NA |
1.3 |
T1c |
BoneMetastasis |
3.22 |
LungMetastasis |
15 |
1 |
3.65 |
N |
3.22 |
3 |
Bad Prognosis |
GSM50095 | NA |
LumA |
IBD |
WID |
ICR3 |
400003150 |
B108-T |
DistantMetastasis |
6.54 |
Recurred/Progressed |
NA |
NA |
54 |
NA |
ER+ |
PR+ |
NA |
2.6 |
T2 |
BoneMetastasisFree |
6.54 |
LungMetastasisFree |
29 |
0 |
7.46 |
N |
7.46 |
1 |
Good Prognosis |
GSM50096 | NA |
ClaudinLow |
IBD |
PID |
ICR2 |
400003151 |
B109-T |
DistantMetastasis |
1.38 |
Recurred/Progressed |
NA |
NA |
32 |
NA |
ER- |
PR- |
NA |
6 |
T3/T4 |
BoneMetastasisFree |
1.38 |
LungMetastasis |
32 |
1 |
1.67 |
N |
1.38 |
2 |
Bad Prognosis |
GSM50097 | NA |
LumB |
IBE |
PID |
ICR1 |
400003152 |
B111-T |
DistantMetastasis |
5.39 |
Recurred/Progressed |
NA |
NA |
46 |
NA |
ER+ |
PR+ |
NA |
1.3 |
T1c |
BoneMetastasis |
5.39 |
LungMetastasisFree |
22 |
0 |
5.39 |
N |
7.11 |
2 |
Good Prognosis |
GSM50098 | NA |
LumA |
IBD |
WID |
ICR2 |
400003153 |
B113-T |
DistantMetastasis |
2.57 |
Recurred/Progressed |
NA |
NA |
49 |
NA |
ER+ |
PR+ |
NA |
1.5 |
T1c |
BoneMetastasis |
2.57 |
LungMetastasisFree |
22 |
1 |
2.57 |
N |
7.53 |
3 |
Good Prognosis |
GSM50099 | NA |
LumA |
IBD |
WID |
ICR2 |
400003154 |
B81-T |
DistantMetastasis |
1.3 |
Recurred/Progressed |
NA |
NA |
31 |
NA |
ER+ |
PR+ |
NA |
2.5 |
T2 |
BoneMetastasis |
1.3 |
LungMetastasisFree |
10 |
1 |
1.3 |
NA |
5.68 |
5 |
Good Prognosis |
GSM50100 | NA |
LumA |
IBD |
PID |
ICR1 |
400003155 |
B88-T |
DistantMetastasis |
5.81 |
Recurred/Progressed |
NA |
NA |
61 |
NA |
ER+ |
PR+ |
NA |
4.8 |
T2 |
BoneMetastasisFree |
5.81 |
LungMetastasisFree |
15 |
0 |
7.96 |
N |
7.96 |
1 |
Good Prognosis |
GSM50101 | NA |
LumA |
IBD |
PID |
ICR2 |
400003156 |
B92-T |
DistantMetastasis |
6.36 |
Recurred/Progressed |
NA |
NA |
72 |
NA |
ER+ |
PR+ |
NA |
2.5 |
T2 |
BoneMetastasis |
6.36 |
LungMetastasisFree |
19 |
0 |
6.36 |
N |
7.58 |
3 |
Good Prognosis |
GSM50102 | NA |
Basal |
IBE |
PID |
ICR1 |
400003157 |
B94-T |
DistantMetastasis |
0.67 |
Recurred/Progressed |
NA |
NA |
48 |
NA |
ER- |
PR- |
NA |
4 |
T2 |
BoneMetastasisFree |
0.67 |
LungMetastasisFree |
18 |
1 |
1.03 |
N |
1.03 |
1 |
Bad Prognosis |
GSM50103 | NA |
Basal |
IBE |
PID |
ICR2 |
400003158 |
B95-T |
DistantMetastasis |
1.84 |
Recurred/Progressed |
NA |
NA |
61 |
NA |
ER- |
PR- |
NA |
3.8 |
T2 |
BoneMetastasisFree |
1.84 |
LungMetastasis |
19 |
1 |
1.84 |
3+ |
1.84 |
3 |
Bad Prognosis |
GSM50104 | NA |
Normal |
IBE |
NA |
ICR2 |
400003159 |
B96-T |
DistantMetastasis |
6.77 |
Recurred/Progressed |
NA |
NA |
65 |
NA |
ER+ |
PR+ |
NA |
2.9 |
T2 |
BoneMetastasis |
6.77 |
LungMetastasisFree |
18 |
0 |
6.77 |
N |
8.89 |
1 |
Good Prognosis |
GSM50105 | NA |
LumA |
IBD |
WID |
ICR3 |
400003160 |
B99-T |
DistantMetastasisFree |
7.19 |
DiseaseFree |
NA |
NA |
54 |
NA |
ER+ |
PR- |
NA |
4.5 |
T2 |
BoneMetastasisFree |
7.19 |
LungMetastasisFree |
19 |
0 |
7.19 |
NA |
7.19 |
1 |
Good Prognosis |
GSM50106 | NA |
ClaudinLow |
IBD |
WID |
ICR3 |
400003161 |
B7-T |
DistantMetastasis |
1.58 |
Recurred/Progressed |
NA |
NA |
60 |
NA |
ER- |
PR- |
NA |
10 |
T3/T4 |
BoneMetastasisFree |
1.58 |
LungMetastasis |
26 |
1 |
1.65 |
N |
1.58 |
15 |
Bad Prognosis |
GSM50107 | NA |
Basal |
IBE |
PID |
ICR2 |
400003162 |
B10-T |
DistantMetastasisFree |
6.21 |
DiseaseFree |
NA |
NA |
52 |
NA |
ER- |
PR- |
NA |
6.5 |
T3/T4 |
BoneMetastasisFree |
6.21 |
LungMetastasisFree |
9 |
0 |
6.21 |
N |
6.21 |
8 |
Bad Prognosis |
GSM50108 | NA |
LumA |
IBD |
WID |
ICR2 |
400003163 |
B11-T |
DistantMetastasisFree |
3.96 |
DiseaseFree |
NA |
NA |
52 |
NA |
ER+ |
PR+ |
NA |
1.8 |
T1c |
BoneMetastasisFree |
3.96 |
LungMetastasisFree |
33 |
NA |
3.96 |
N |
3.96 |
12 |
Good Prognosis |
GSM50109 | NA |
NA |
NA |
NA |
NA |
400003164 |
B12-T |
NA |
NA |
NA |
NA |
NA |
57 |
NA |
ER+ |
PR+ |
NA |
2 |
T1c |
NA |
NA |
NA |
21 |
NA |
NA |
NA |
NA |
1 |
NA |
GSM50110 | NA |
Basal |
IBE |
FID |
ICR4 |
400003165 |
B13-T |
DistantMetastasisFree |
5.19 |
DiseaseFree |
NA |
NA |
44 |
NA |
ER- |
PR- |
NA |
6.1 |
T3/T4 |
BoneMetastasisFree |
5.19 |
LungMetastasisFree |
15 |
0 |
5.19 |
N |
5.19 |
1 |
Bad Prognosis |
GSM50111 | NA |
LumA |
IBD |
PID |
ICR1 |
400003166 |
B14-T |
DistantMetastasisFree |
7.3 |
DiseaseFree |
NA |
NA |
61 |
NA |
ER+ |
PR+ |
NA |
5 |
T2 |
BoneMetastasisFree |
7.3 |
LungMetastasisFree |
33 |
0 |
7.3 |
N |
7.3 |
30 |
Good Prognosis |
GSM50112 | NA |
Basal |
IBE |
PID |
ICR2 |
400003167 |
B15-T |
DistantMetastasis |
1.18 |
Recurred/Progressed |
NA |
NA |
43 |
NA |
ER+ |
PR- |
NA |
4.5 |
T2 |
BoneMetastasis |
1.18 |
LungMetastasis |
21 |
1 |
1.18 |
N |
1.18 |
1 |
Bad Prognosis |
GSM50113 | NA |
NA |
NA |
NA |
NA |
400003168 |
B16-T |
NA |
NA |
NA |
NA |
NA |
56 |
NA |
ER+ |
PR+ |
NA |
2.6 |
T2 |
NA |
NA |
NA |
26 |
NA |
NA |
1+ |
NA |
5 |
NA |
GSM50114 | NA |
LumA |
IBD |
FID |
ICR3 |
400003169 |
B17-T |
DistantMetastasis |
1.3 |
Recurred/Progressed |
NA |
NA |
62 |
NA |
ER+ |
PR+ |
NA |
3.5 |
T2 |
BoneMetastasis |
1.3 |
LungMetastasisFree |
21 |
1 |
1.3 |
N |
1.3 |
20 |
Good Prognosis |
GSM50115 | NA |
LumA |
IBD |
WID |
ICR2 |
400003170 |
B18-T |
DistantMetastasisFree |
4.42 |
DiseaseFree |
NA |
NA |
40 |
NA |
ER+ |
PR+ |
NA |
3.5 |
T2 |
BoneMetastasisFree |
4.42 |
LungMetastasisFree |
26 |
NA |
4.42 |
N |
4.42 |
17 |
Good Prognosis |
GSM50116 | NA |
Normal |
IBE |
NA |
ICR2 |
400003171 |
B1-T |
DistantMetastasisFree |
3.58 |
DiseaseFree |
NA |
NA |
65 |
NA |
ER- |
PR- |
NA |
7.5 |
T3/T4 |
BoneMetastasisFree |
3.58 |
LungMetastasisFree |
19 |
NA |
3.58 |
2+ |
3.58 |
4 |
Bad Prognosis |
GSM50117 | NA |
NA |
NA |
NA |
NA |
400003172 |
B23-T |
NA |
NA |
NA |
NA |
NA |
38 |
NA |
ER+ |
PR+ |
NA |
1.5 |
T1c |
NA |
NA |
NA |
17 |
NA |
NA |
3+ |
NA |
17 |
NA |
GSM50118 | NA |
LumB |
IBD |
PID |
ICR3 |
400003173 |
B24-T |
DistantMetastasisFree |
6.28 |
DiseaseFree |
NA |
NA |
72 |
NA |
ER+ |
PR+ |
NA |
3 |
T2 |
BoneMetastasisFree |
6.28 |
LungMetastasisFree |
23 |
0 |
6.28 |
N |
6.28 |
5 |
Bad Prognosis |
GSM50119 | NA |
Basal |
IBE |
WID |
ICR3 |
400003174 |
B26-T |
DistantMetastasisFree |
4.18 |
DiseaseFree |
NA |
NA |
54 |
NA |
ER- |
PR- |
NA |
4 |
T2 |
BoneMetastasisFree |
4.18 |
LungMetastasisFree |
31 |
NA |
4.18 |
1+ |
4.18 |
7 |
Bad Prognosis |
GSM50120 | NA |
NA |
IBE |
NA |
ICR3 |
400003175 |
B27-T |
DistantMetastasisFree |
3.68 |
DiseaseFree |
NA |
NA |
38 |
NA |
ER+ |
PR+ |
NA |
4.1 |
T2 |
BoneMetastasisFree |
3.68 |
LungMetastasisFree |
31 |
NA |
3.68 |
N |
3.68 |
5 |
Bad Prognosis |
GSM50121 | NA |
LumA |
IBD |
PID |
ICR1 |
400003176 |
B28-T |
DistantMetastasisFree |
4.12 |
DiseaseFree |
NA |
NA |
54 |
NA |
ER+ |
PR+ |
NA |
6 |
T3/T4 |
BoneMetastasisFree |
4.12 |
LungMetastasisFree |
27 |
NA |
4.12 |
1+ |
4.12 |
6 |
Good Prognosis |
GSM50122 | NA |
LumB |
IBD |
FID |
ICR4 |
400003177 |
B29-T |
DistantMetastasis |
3.24 |
Recurred/Progressed |
NA |
NA |
43 |
NA |
ER+ |
PR+ |
NA |
8 |
T3/T4 |
BoneMetastasis |
3.24 |
LungMetastasisFree |
36 |
1 |
3.24 |
N |
4.07 |
22 |
Bad Prognosis |
GSM50123 | NA |
Basal |
IBE |
FID |
ICR4 |
400003178 |
B2-T |
DistantMetastasisFree |
3.9 |
DiseaseFree |
NA |
NA |
59 |
NA |
ER- |
PR- |
NA |
4.5 |
T2 |
BoneMetastasisFree |
3.9 |
LungMetastasisFree |
21 |
NA |
3.9 |
N |
3.9 |
10 |
Bad Prognosis |
GSM50124 | NA |
NA |
NA |
NA |
NA |
400003179 |
B31-T |
NA |
NA |
NA |
NA |
NA |
87 |
NA |
ER+ |
PR+ |
NA |
2.9 |
T2 |
NA |
NA |
NA |
20 |
NA |
NA |
N |
NA |
2 |
NA |
GSM50125 | NA |
NA |
NA |
NA |
NA |
400003180 |
B32-T |
NA |
NA |
NA |
NA |
NA |
59 |
NA |
ER- |
PR- |
NA |
7 |
T3/T4 |
NA |
NA |
NA |
17 |
NA |
NA |
1+ |
NA |
1 |
NA |
GSM50126 | NA |
NA |
NA |
NA |
NA |
400003181 |
B33-T |
NA |
NA |
NA |
NA |
NA |
38 |
NA |
ER+ |
PR+ |
NA |
3.5 |
T2 |
NA |
NA |
NA |
16 |
NA |
NA |
3+ |
NA |
2 |
NA |
GSM50127 | NA |
Her2 |
IBD |
WID |
ICR4 |
400003182 |
B3-T |
DistantMetastasisFree |
5.24 |
DiseaseFree |
NA |
NA |
59 |
NA |
ER+ |
PR+ |
NA |
6 |
T3/T4 |
BoneMetastasisFree |
5.24 |
LungMetastasisFree |
29 |
0 |
5.24 |
1+ (only 1 core pos.) |
5.24 |
4 |
Bad Prognosis |
GSM50128 | NA |
LumA |
IBD |
PID |
ICR2 |
400003183 |
B4-T |
DistantMetastasisFree |
2.3 |
DiseaseFree |
NA |
NA |
70 |
NA |
ER+ |
PR+ |
NA |
3 |
T2 |
BoneMetastasisFree |
2.3 |
LungMetastasisFree |
11 |
NA |
2.3 |
1+ |
2.3 |
6 |
Good Prognosis |
GSM50129 | NA |
NA |
NA |
NA |
NA |
400003184 |
B5-T |
NA |
NA |
NA |
NA |
NA |
39 |
NA |
ER+ |
PR- |
NA |
6 |
T3/T4 |
NA |
NA |
NA |
22 |
NA |
NA |
NA |
NA |
6 |
NA |
GSM50130 | NA |
Basal |
IBE |
WID |
ICR3 |
400003185 |
B6-T |
DistantMetastasisFree |
3.36 |
DiseaseFree |
NA |
NA |
54 |
NA |
ER- |
PR- |
NA |
3 |
T2 |
BoneMetastasisFree |
3.36 |
LungMetastasisFree |
23 |
NA |
3.36 |
3+ |
3.36 |
18 |
Bad Prognosis |
GSM50131 | NA |
LumB |
IBD |
FID |
ICR3 |
400003186 |
B8-T |
DistantMetastasis |
4.59 |
Recurred/Progressed |
NA |
NA |
42 |
NA |
ER+ |
PR+ |
NA |
3.9 |
T2 |
BoneMetastasis |
4.59 |
LungMetastasisFree |
28 |
1 |
4.59 |
N |
6.05 |
24 |
Bad Prognosis |
GSM50132 | NA |
NA |
NA |
NA |
NA |
400003187 |
B9-T |
NA |
NA |
NA |
NA |
NA |
74 |
NA |
ER+ |
PR- |
NA |
3.9 |
T2 |
NA |
NA |
NA |
31 |
NA |
NA |
N |
NA |
29 |
NA |
Name | ||
---|---|---|
All Samples | Default | View |
Immune Benefit Status | View | |
Immunological Constant of Rejection | View | |
Molecular Subtype | View | |
Pathology T Stage | View | |
In order to make new Group Sets or change settings, please log in. |
Group Set | |
---|---|
All Samples | |
Immune Benefit Status | |
Immunological Constant of Rejection | |
Molecular Subtype | |
Pathology T Stage |